Atlas Trials

Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection

Clinical trial NCT05620017 · RECRUITING

Trial details

NCT number
NCT05620017
Sponsor
Bio-Thera Solutions
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid Tumors
Start date
2022-11-30
Primary completion
2027-05-31
Enrollment
182

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.